It is produced by the strain of Semisynthetic third generation cephalosporin for injection. Cefodizime has broad-spectrum antibacterial activity against aerobic gram positive and gram negative bacteria. Clinically, it has been shown to be effective against upper and lower respiratory tract infections, urinary tract infections, and gonorrhea. Cefodizime is a bactericidal antibiotic that targets penicillin-binding proteins (PBPs) 1A/B, 2, and 3 resulting in the eventual death of the bacterial cell. It also has immunomodulatory effect.